It is reported that KKR is selling BridgeBio Pharma shares at a price of up to $80 per share.

On August 13, local time, it was reported that sources revealed an affiliate of the private equity investment firm KKR is selling shares of the biotechnology company BridgeBio Pharma at a price of $78 to $80 per share.